167 related articles for article (PubMed ID: 36289663)
41. Isotype distribution of anti-cyclic citrullinated peptide antibodies in undifferentiated arthritis and rheumatoid arthritis reflects an ongoing immune response.
Verpoort KN; Jol-van der Zijde CM; Papendrecht-van der Voort EA; Ioan-Facsinay A; Drijfhout JW; van Tol MJ; Breedveld FC; Huizinga TW; Toes RE
Arthritis Rheum; 2006 Dec; 54(12):3799-808. PubMed ID: 17133560
[TBL] [Abstract][Full Text] [Related]
42. Presence and utility of IgA-class antibodies to cyclic citrullinated peptides in early rheumatoid arthritis: the Swedish TIRA project.
Svärd A; Kastbom A; Reckner-Olsson A; Skogh T
Arthritis Res Ther; 2008; 10(4):R75. PubMed ID: 18601717
[TBL] [Abstract][Full Text] [Related]
43. Inhibitory Effect of Tetramerized Single-Chain Variable Fragment of Anti-Cyclic Citrullinated Peptide Antibodies on the Proliferation, Activation, and Secretion of Cytokines of Fibroblast-Like Synoviocytes in Rheumatoid Arthritis In Vitro Co-Culture System.
Wang J; Tie N; Li H; Kang X
Inflammation; 2020 Dec; 43(6):2245-2255. PubMed ID: 32737657
[TBL] [Abstract][Full Text] [Related]
44. Prediction of radiological outcome in early rheumatoid arthritis in clinical practice: role of antibodies to citrullinated peptides (anti-CCP).
Forslind K; Ahlmén M; Eberhardt K; Hafström I; Svensson B;
Ann Rheum Dis; 2004 Sep; 63(9):1090-5. PubMed ID: 15308518
[TBL] [Abstract][Full Text] [Related]
45. Synovial fluid levels of anti-cyclic citrullinated peptide antibodies and IgA rheumatoid factor in rheumatoid arthritis, psoriatic arthritis, and osteoarthritis.
Caspi D; Anouk M; Golan I; Paran D; Kaufman I; Wigler I; Levartovsky D; Litinsky I; Elkayam O
Arthritis Rheum; 2006 Feb; 55(1):53-6. PubMed ID: 16463412
[TBL] [Abstract][Full Text] [Related]
46. Diagnostic value of anti-cyclic citrullinated Peptide antibody in patients with rheumatoid arthritis.
Zeng X; Ai M; Tian X; Gan X; Shi Y; Song Q; Tang F
J Rheumatol; 2003 Jul; 30(7):1451-5. PubMed ID: 12858440
[TBL] [Abstract][Full Text] [Related]
47. Long-term follow-up of patients with anti-cyclic citrullinated peptide antibody-positive connective tissue disease: a retrospective observational study including information on the HLA-DRB1 allele and citrullination dependency.
Iwasaki T; Nakabo S; Terao C; Murakami K; Nakashima R; Hashimoto M; Imura Y; Yukawa N; Yoshifuji H; Miura Y; Yurugi K; Maekawa T; van Delft MAM; Trouw LA; Fujii T; Mimori T; Ohmura K
Arthritis Res Ther; 2020 Oct; 22(1):248. PubMed ID: 33076960
[TBL] [Abstract][Full Text] [Related]
48. Anti-cyclic citrullinated peptide antibody in the cerebrospinal fluid in patients with rheumatoid arthritis who have central nervous system involvement.
Higashida-Konishi M; Izumi K; Tsukamoto M; Ohya H; Takasugi N; Hama S; Hayashi Y; Ushikubo M; Akiya K; Kazuhiro A; Okano Y; Oshima H
Clin Rheumatol; 2020 Aug; 39(8):2441-2448. PubMed ID: 32356228
[TBL] [Abstract][Full Text] [Related]
49. Multiple antibody reactivities to citrullinated antigens in sera from patients with rheumatoid arthritis: association with HLA-DRB1 alleles.
Snir O; Widhe M; von Spee C; Lindberg J; Padyukov L; Lundberg K; Engström A; Venables PJ; Lundeberg J; Holmdahl R; Klareskog L; Malmström V
Ann Rheum Dis; 2009 May; 68(5):736-43. PubMed ID: 18635594
[TBL] [Abstract][Full Text] [Related]
50. Anti-cyclic citrullinated peptide antibody in rheumatoid arthritis: relation with disease aggressiveness.
del Val del Amo N; Ibanez Bosch R; Fito Manteca C; Gutierrez Polo R; Loza Cortina E
Clin Exp Rheumatol; 2006; 24(3):281-6. PubMed ID: 16870095
[TBL] [Abstract][Full Text] [Related]
51. Changes in anti-cyclic citrullinated peptide antibodies and rheumatoid factor isotypes serum levels in patients with rheumatoid arthritis following treatment with different biological drugs.
Iannone F; Tampoia M; Giannini M; Lopalco G; Cantarini L; Villalta CD; Galeazzi M; Lapadula G
Clin Exp Rheumatol; 2016; 34(3):424-9. PubMed ID: 26885600
[TBL] [Abstract][Full Text] [Related]
52. Anticyclic citrullinated peptide antibody in rheumatoid arthritis:a cross-sectional study in Iran.
Shenavar Masooleh I; Hajiabbasi A; Zayeni H; Ghanbari A; Zaker Esteghamati V; Ghavidel Parsa B; Hassankhani A
Turk J Med Sci; 2016 Nov; 46(5):1309-1313. PubMed ID: 27966336
[TBL] [Abstract][Full Text] [Related]
53. Early diagnostic and prognostic values of anti-cyclic citrullinated peptide antibody and cartilage oligomeric matrix protein in rheumatoid arthritis.
Algergawy SA; Abd El-Sabour M; Osman AS; Emam SM; Elham N
Egypt J Immunol; 2013; 20(2):11-20. PubMed ID: 24617043
[TBL] [Abstract][Full Text] [Related]
54. Correlation of anti-cyclic citrullinated antibody with hand joint erosion score in rheumatoid arthritis patients.
Kim HH; Kim J; Park SH; Kim SK; Kim OD; Choe JY
Korean J Intern Med; 2010 Jun; 25(2):201-6. PubMed ID: 20526395
[TBL] [Abstract][Full Text] [Related]
55. Anti-cyclic citrullinated peptide antibody is a good indicator for the diagnosis of rheumatoid arthritis.
Abdul Wahab A; Mohammad M; Rahman MM; Mohamed Said MS
Pak J Med Sci; 2013 May; 29(3):773-7. PubMed ID: 24353626
[TBL] [Abstract][Full Text] [Related]
56. Detection of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis patients undergoing total knee arthroplasty.
Guo CJ; Lv JH; Niu DS; Ma T; Sun SX; Li LX; Zhao X; Wu L; Jin QH
Int J Clin Exp Med; 2015; 8(3):4410-4. PubMed ID: 26064362
[TBL] [Abstract][Full Text] [Related]
57. [Analysis of clinical significance of anti-cyclic citrullinated peptide antibody (anti-CCP antibody) in rheumatoid arthritis (RA)].
Shimoyama K; Ogawa N; Sakai T; Sawaki T; Kawanami T; Karasawa H; Masaki Y; Tanaka M; Fukushima T; Hirose Y; Umehara H
Nihon Rinsho Meneki Gakkai Kaishi; 2007 Oct; 30(5):408-13. PubMed ID: 17984582
[TBL] [Abstract][Full Text] [Related]
58. Anti-cyclic citrullinated peptide antibodies are highly associated with severe bone lesions in rheumatoid arthritis anti-CCP and bone damage in RA.
Bongi SM; Manetti R; Melchiorre D; Turchini S; Boccaccini P; Vanni L; Maggi E
Autoimmunity; 2004; 37(6-7):495-501. PubMed ID: 15621577
[TBL] [Abstract][Full Text] [Related]
59. Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis.
Nishimura K; Sugiyama D; Kogata Y; Tsuji G; Nakazawa T; Kawano S; Saigo K; Morinobu A; Koshiba M; Kuntz KM; Kamae I; Kumagai S
Ann Intern Med; 2007 Jun; 146(11):797-808. PubMed ID: 17548411
[TBL] [Abstract][Full Text] [Related]
60. Rheumatoid arthritis presenting as rheumatoid meningitis.
McKenna MC; Vaughan D; Bermingham N; Cronin S
BMJ Case Rep; 2019 Jan; 12(1):. PubMed ID: 30635304
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
